Roots Analysis

JANUARY 23, 2024

Owing to the challenges involved in the synthesis process and demands of modern drug development, majority of drug developers in this domain prefer to outsource their development and manufacturing operations to peptide therapeutics contract API manufacturers as a strategic solution to streamline their research and peptide synthesis efforts.

Development 40

Development Contract Manufacturing Drugs Manufacturing 40

The Pharma Data

AUGUST 20, 2020

The drugmakers lost out to domestic producers, which in some cases undercut prices for established medicines by more than 90%, according to Jiemian. Among the drugs to lose contracts were Eli Lilly schizophrenia medicine Zyprexa and Pfizer’s Viagra, the publication said. DEVELOP A UNIFIED SCIENTIFIC VOICE. Virtual Event.

Research Analyst 52

Research Analyst Medicine Pharma Companies Marketing 52

The Pharma Data

DECEMBER 31, 2020

where he led global clinical development programs including clinical strategy, clinical development, and regulatory affairs. Reimer replaces Charlotte Russel and will be responsible for Alligator’s drug development candidates, with an emphasis on bringing mitazalimab and ATOR-1017 into Phase II efficacy studies.

Gene Therapy 52

Gene Therapy Engineer Gene Research Analyst 52

The Pharma Data

DECEMBER 28, 2020

28, 2020 /PRNewswire/ — Novotech Health Holdings (“Novotech Holdings”), the largest biotech specialist contract research organization (CRO) in Asia , today announced the appointment of Zidong Zhang as Chief Financial Officer (CFO) effective 4 January 2021. SHANGHAI and SYDNEY , Dec. ” ABOUT NOVOTECH HEALTH HOLDINGS.

Clinical Trials 40

Clinical Trials Clinical Trials Research Analyst Trials 40

Roots Analysis

FEBRUARY 23, 2024

These experts are like the superhero squad for medical research. This helps to speed up the process of making new medicines and finding cures for diseases. Companies are now turning to contract research organizations to help accelerate their workflow.

Antibody 40

Antibody Research Marketing Scientist 40

Pharmaceutical Technology

JANUARY 27, 2023

In 2019, Cablivi became the first FDA-approved , nanobody-based medicine for acquired thrombotic thrombocytopenic purpura (aTTP), an ultra-orphan condition that causes blood clots in small blood vessels around the body. The disorder has a reported annual incidence between 1.5 cases per million in Europe.

Manufacturing 130

Manufacturing Drugs Research Analyst FDA Approval 130